Effects of Mammography Screening Under Different Screening Schedules: Model Estimates of Potential Benefits and Harms

被引:479
作者
Mandelblatt, Jeanne S. [1 ]
Cronin, Kathleen A.
Bailey, Stephanie
Berry, Donald A.
de Koning, Harry J.
Draisma, Gerrit
Huang, Hui
Lee, Sandra J.
Munsell, Mark
Plevritis, Sylvia K.
Ravdin, Peter
Schechter, Clyde B.
Sigal, Bronislava
Stoto, Michael A.
Stout, Natasha K.
van Ravesteyn, Nicolien T.
Venier, John
Zelen, Marvin
Feuer, Eric J.
机构
[1] Lombardi Comprehens Canc Ctr, Washington, DC 20007 USA
关键词
CARCINOMA IN-SITU; BREAST-CANCER MORTALITY; UPPER AGE LIMIT; COST-EFFECTIVENESS; FOLLOW-UP; WOMEN; OLDER; OVERDIAGNOSIS; OVERTREATMENT; PERFORMANCE;
D O I
10.7326/0003-4819-151-10-200911170-00010
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Despite trials of mammography and widespread use, optimal screening policy is controversial. Objective: To evaluate U. S. breast cancer screening strategies. Design: 6 models using common data elements. Data Sources: National data on age-specific incidence, competing mortality, mammography characteristics, and treatment effects. Target Population: A contemporary population cohort. Time Horizon: Lifetime. Perspective: Societal. Interventions: 20 screening strategies with varying initiation and cessation ages applied annually or biennially. Outcome Measures: Number of mammograms, reduction in deaths from breast cancer or life-years gained (vs. no screening), false-positive results, unnecessary biopsies, and overdiagnosis. Results of Base-Case Analysis: The 6 models produced consistent rankings of screening strategies. Screening biennially maintained an average of 81% (range across strategies and models, 67% to 99%) of the benefit of annual screening with almost half the number of false-positive results. Screening biennially from ages 50 to 69 years achieved a median 16.5% (range, 15% to 23%) reduction in breast cancer deaths versus no screening. Initiating biennial screening at age 40 years (vs. 50 years) reduced mortality by an additional 3% (range, 1% to 6%), consumed more resources, and yielded more false-positive results. Biennial screening after age 69 years yielded some additional mortality reduction in all models, but overdiagnosis increased most substantially at older ages. Results of Sensitivity Analysis: Varying test sensitivity or treatment patterns did not change conclusions. Limitation: Results do not include morbidity from false-positive results, patient knowledge of earlier diagnosis, or unnecessary treatment. Conclusion: Biennial screening achieves most of the benefit of annual screening with less harm. Decisions about the best strategy depend on program and individual objectives and the weight placed on benefits, harms, and resource considerations.
引用
收藏
页码:738 / W247
页数:15
相关论文
共 50 条
[41]   Analysis of Mammography Screening Policies under Resource Constraints [J].
Cevik, Mucahit ;
Ayer, Turgay ;
Alagoz, Oguzhan ;
Sprague, Brian L. .
PRODUCTION AND OPERATIONS MANAGEMENT, 2018, 27 (05) :949-972
[42]   Benefits and harms of breast cancer mammography screening for women at average risk of breast cancer: A systematic review for the European Commission Initiative on Breast Cancer [J].
Canelo-Aybar, Carlos ;
Ferreira, Diogenes S. ;
Ballesteros, Monica ;
Posso, Margarita ;
Montero, Nadia ;
Sola, Ivan ;
Saz-Parkinson, Zuleika ;
Lerda, Donata ;
Rossi, Paolo G. ;
Duffy, Stephen W. ;
Follmann, Markus ;
Graewingholt, Axel ;
Alonso-Coello, Pablo .
JOURNAL OF MEDICAL SCREENING, 2021, 28 (04) :389-404
[43]   Imaging-based screening: maximizing benefits and minimizing harms [J].
Germino, Jessica C. ;
Elmore, Joann G. ;
Carlos, Ruth C. ;
Lee, Christoph I. .
CLINICAL IMAGING, 2016, 40 (02) :339-343
[44]   Skeptical Reactions to Breast Cancer Screening Benefits and Harms: Antecedents, Consequences, and Implications for Screening Communication [J].
Scherer, Laura D. ;
Lewis, Carmen L. ;
Cappella, Joseph N. ;
Hersch, Jolyn ;
Mccaffery, Kirsten ;
Tate, Channing ;
Smyth, Heather L. ;
Mosley, Bridget ;
Morse, Brad ;
Schapira, Marilyn M. .
HEALTH PSYCHOLOGY, 2025, 44 (06) :608-619
[45]   Shift in harms and benefits of cervical cancer screening in the era of HPV screening and vaccination: a modelling study [J].
Kaljouw, Sylvia ;
Jansen, Erik E. L. ;
Aitken, Clare A. ;
de Kok, Inge M. C. M. .
BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 2022, 129 (11) :1862-1869
[46]   Quality-of-life effects of screening mammography in Norway [J].
Zahl, Per-Henrik ;
Kalager, Mette ;
Suhrke, Pal ;
Nord, Erik .
INTERNATIONAL JOURNAL OF CANCER, 2020, 146 (08) :2104-2112
[47]   Maximizing the benefits of screening mammography for women 40-49 years old [J].
Bastardis-Zakas, K. ;
Iatrakis, G. ;
Navrozoglou, I. ;
Peitsidis, P. ;
Salakos, N. ;
Malakassis, P. ;
Zervoudis, S. .
CLINICAL AND EXPERIMENTAL OBSTETRICS & GYNECOLOGY, 2010, 37 (04) :278-282
[48]   Estimating the Harms and Benefits of Prostate Cancer Screening as Used in Common Practice Versus Recommended Good Practice: A Microsimulation Screening Analysis [J].
Carlsson, Sigrid V. ;
de Carvalho, Tiago M. ;
Roobol, Monique J. ;
Hugosson, Jonas ;
Auvinen, Anssi ;
Kwiatkowski, Maciej ;
Villers, Arnauld ;
Zappa, Marco ;
Nelen, Vera ;
Paez, Alvaro ;
Eastham, James A. ;
Lilja, Hans ;
de Koning, Harry J. ;
Vickers, Andrew J. ;
Heijnsdijk, Eveline A. M. .
CANCER, 2016, 122 (21) :3386-3393
[49]   Different BIRADS Categories in Screening and Diagnostic Mammography [J].
Ehsanbakhsh, A. R. ;
Toosi, F. Sailanian ;
Khorashadizadeh, N. .
IRANIAN JOURNAL OF RADIOLOGY, 2009, 6 (03) :119-123
[50]   Estimates of overdiagnosis of invasive breast cancer associated with screening mammography [J].
Stephen Morrell ;
Alexandra Barratt ;
Les Irwig ;
Kirsten Howard ;
Corné Biesheuvel ;
Bruce Armstrong .
Cancer Causes & Control, 2010, 21 :275-282